Placeholder for OIG CLFS Report CY2018 (Due in 2017)

For the last several years, OIG issued a PAMA-related CLFS report every fall based on data from the prior year.  It counted lab test payments for OPPS setting (hospital outreach labs billing on the 1450 form) as well as Part B CLFS.

The 2018 report will be the first that looks retrospectively at a year of new pricing under PAMA. 

As of February 2020, OIG has a placeholder page for the report, but it hasn't come out yet.

https://www.oig.hhs.gov/reports-and-publications/workplan/summary/wp-summary-0000336.asp

Medicare Payments for Clinical Diagnostic Laboratory Tests in 2018: Year 1 of New Payment Rates

Medicare is the largest payer of clinical laboratory services in the Nation. Medicare Part B covers most lab tests and pays 100 percent of allowable charges, with no beneficiary copayment. In 2017, Medicare paid $7.1 billion for lab tests, a total that has changed very little in the 4-year period from 2014 through 2017. The Protecting Access to Medicare Act of 2014 (PAMA) requires CMS to set payment rates for lab tests using current charges in the private health-care market, under Title XVIII of the Social Security Act. (Pub. L. No. 113-93 § 216(c)(2)(A)). On January 1, 2018, CMS began paying for lab tests under the new system mandated by PAMA. PAMA requires OIG to publicly release an annual analysis of the top 25 laboratory tests by expenditures. In accordance with PAMA, we will publicly release an analysis of the top 25 laboratory tests by expenditures for 2018, the first year of payments made under the new system for setting payment rates.

Announced or Revised	Agency	Title	Component	Report Number(s)	Expected Issue Date (FY)
June 2019	Centers for Medicare & Medicaid Services	Medicare Payments for Clinical Diagnostic Laboratory Tests in 2018: Year 1 of New Payment Rates	Office of Evaluation and Inspections	OEI-09-18-00100	2020